Pharma & Healthcare
Global Stem Cell Therapy for Osteoarthritis Market Research Report 2024
- Mar 03, 24
- ID: 110570
- Pages: 61
- Figures: 118
- Views: 19
OA is the most common degenerative joint disease. Its initial symptoms include loss of articular cartilage followed by progressive to joint stiffness, swelling, pain, and loss of mobility.
Stem cells are the body's raw materials — cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells either become new stem cells (self-renewal) or become specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells or bone cells. No other cell in the body has the natural ability to generate new cell types.
Most stem cells used for the experimental treatment of OA are adult MSCs. Researchers can easily collect them from fat or bone marrow. MSCs are able to turn into cartilage, bone, muscle, tendon, ligaments, or fat, depending on the type of tissue that surrounds them. This is why researchers are studying MSCs in stem cell treatments for OA.
The global Stem Cell Therapy for Osteoarthritis market was valued at US$ 22 million in 2023 and is anticipated to reach US$ 107.3 million by 2030, witnessing a CAGR of 25.1% during the forecast period 2024-2030.
In the global market, the core manufacturers of Stem cell therapy for osteoarthritis include Medipost etc, and the top 1 manufacturer accounts for about 80% of the market share. The market include Asia Pacific and Europe, with a share of 90% and 10%. allogeneic accounted for 90% and autologous accounted for 10%. the product is mainly used in primary osteoarthritis and secondary osteoarthritis fields, with a share of 92% and 8%.
This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy for Osteoarthritis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy for Osteoarthritis.
Report Scope
The Stem Cell Therapy for Osteoarthritis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Stem Cell Therapy for Osteoarthritis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stem Cell Therapy for Osteoarthritis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medipost
Nature Cell
Theracell Advanced Biotechnology
Takeda (TiGenix)
Segment by Type
Allogeneic
Autologous
Segment by Application
Primary Osteoarthritis
Secondary Osteoarthritis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stem Cell Therapy for Osteoarthritis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Stem cells are the body's raw materials — cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells either become new stem cells (self-renewal) or become specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells or bone cells. No other cell in the body has the natural ability to generate new cell types.
Most stem cells used for the experimental treatment of OA are adult MSCs. Researchers can easily collect them from fat or bone marrow. MSCs are able to turn into cartilage, bone, muscle, tendon, ligaments, or fat, depending on the type of tissue that surrounds them. This is why researchers are studying MSCs in stem cell treatments for OA.
The global Stem Cell Therapy for Osteoarthritis market was valued at US$ 22 million in 2023 and is anticipated to reach US$ 107.3 million by 2030, witnessing a CAGR of 25.1% during the forecast period 2024-2030.
In the global market, the core manufacturers of Stem cell therapy for osteoarthritis include Medipost etc, and the top 1 manufacturer accounts for about 80% of the market share. The market include Asia Pacific and Europe, with a share of 90% and 10%. allogeneic accounted for 90% and autologous accounted for 10%. the product is mainly used in primary osteoarthritis and secondary osteoarthritis fields, with a share of 92% and 8%.
This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy for Osteoarthritis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy for Osteoarthritis.
Report Scope
The Stem Cell Therapy for Osteoarthritis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Stem Cell Therapy for Osteoarthritis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stem Cell Therapy for Osteoarthritis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medipost
Nature Cell
Theracell Advanced Biotechnology
Takeda (TiGenix)
Segment by Type
Allogeneic
Autologous
Segment by Application
Primary Osteoarthritis
Secondary Osteoarthritis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stem Cell Therapy for Osteoarthritis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Allogeneic
1.2.3 Autologous
1.3 Market by Application
1.3.1 Global Stem Cell Therapy for Osteoarthritis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Primary Osteoarthritis
1.3.3 Secondary Osteoarthritis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Therapy for Osteoarthritis Market Perspective (2019-2030)
2.2 Stem Cell Therapy for Osteoarthritis Growth Trends by Region
2.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Stem Cell Therapy for Osteoarthritis Historic Market Size by Region (2019-2024)
2.2.3 Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Region (2025-2030)
2.3 Stem Cell Therapy for Osteoarthritis Market Dynamics
2.3.1 Stem Cell Therapy for Osteoarthritis Industry Trends
2.3.2 Stem Cell Therapy for Osteoarthritis Market Drivers
2.3.3 Stem Cell Therapy for Osteoarthritis Market Challenges
2.3.4 Stem Cell Therapy for Osteoarthritis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue
3.1.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue (2019-2024)
3.1.2 Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Players (2019-2024)
3.2 Global Stem Cell Therapy for Osteoarthritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Stem Cell Therapy for Osteoarthritis Revenue
3.4 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio
3.4.1 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Osteoarthritis Revenue in 2023
3.5 Stem Cell Therapy for Osteoarthritis Key Players Head office and Area Served
3.6 Key Players Stem Cell Therapy for Osteoarthritis Product Solution and Service
3.7 Date of Enter into Stem Cell Therapy for Osteoarthritis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Therapy for Osteoarthritis Breakdown Data by Type
4.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Type (2019-2024)
4.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Type (2025-2030)
5 Stem Cell Therapy for Osteoarthritis Breakdown Data by Application
5.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Application (2019-2024)
5.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Stem Cell Therapy for Osteoarthritis Market Size (2019-2030)
6.2 North America Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024)
6.4 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stem Cell Therapy for Osteoarthritis Market Size (2019-2030)
7.2 Europe Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024)
7.4 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size (2019-2030)
8.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2019-2024)
8.4 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size (2019-2030)
9.2 Latin America Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024)
9.4 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size (2019-2030)
10.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024)
10.4 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medipost
11.1.1 Medipost Company Detail
11.1.2 Medipost Business Overview
11.1.3 Medipost Stem Cell Therapy for Osteoarthritis Introduction
11.1.4 Medipost Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.1.5 Medipost Recent Development
11.2 Nature Cell
11.2.1 Nature Cell Company Detail
11.2.2 Nature Cell Business Overview
11.2.3 Nature Cell Stem Cell Therapy for Osteoarthritis Introduction
11.2.4 Nature Cell Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.2.5 Nature Cell Recent Development
11.3 Theracell Advanced Biotechnology
11.3.1 Theracell Advanced Biotechnology Company Detail
11.3.2 Theracell Advanced Biotechnology Business Overview
11.3.3 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Introduction
11.3.4 Theracell Advanced Biotechnology Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.3.5 Theracell Advanced Biotechnology Recent Development
11.4 Takeda (TiGenix)
11.4.1 Takeda (TiGenix) Company Detail
11.4.2 Takeda (TiGenix) Business Overview
11.4.3 Takeda (TiGenix) Stem Cell Therapy for Osteoarthritis Introduction
11.4.4 Takeda (TiGenix) Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.4.5 Takeda (TiGenix) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Allogeneic
1.2.3 Autologous
1.3 Market by Application
1.3.1 Global Stem Cell Therapy for Osteoarthritis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Primary Osteoarthritis
1.3.3 Secondary Osteoarthritis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Therapy for Osteoarthritis Market Perspective (2019-2030)
2.2 Stem Cell Therapy for Osteoarthritis Growth Trends by Region
2.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Stem Cell Therapy for Osteoarthritis Historic Market Size by Region (2019-2024)
2.2.3 Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Region (2025-2030)
2.3 Stem Cell Therapy for Osteoarthritis Market Dynamics
2.3.1 Stem Cell Therapy for Osteoarthritis Industry Trends
2.3.2 Stem Cell Therapy for Osteoarthritis Market Drivers
2.3.3 Stem Cell Therapy for Osteoarthritis Market Challenges
2.3.4 Stem Cell Therapy for Osteoarthritis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue
3.1.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue (2019-2024)
3.1.2 Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Players (2019-2024)
3.2 Global Stem Cell Therapy for Osteoarthritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Stem Cell Therapy for Osteoarthritis Revenue
3.4 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio
3.4.1 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Osteoarthritis Revenue in 2023
3.5 Stem Cell Therapy for Osteoarthritis Key Players Head office and Area Served
3.6 Key Players Stem Cell Therapy for Osteoarthritis Product Solution and Service
3.7 Date of Enter into Stem Cell Therapy for Osteoarthritis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Therapy for Osteoarthritis Breakdown Data by Type
4.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Type (2019-2024)
4.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Type (2025-2030)
5 Stem Cell Therapy for Osteoarthritis Breakdown Data by Application
5.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Application (2019-2024)
5.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Stem Cell Therapy for Osteoarthritis Market Size (2019-2030)
6.2 North America Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024)
6.4 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stem Cell Therapy for Osteoarthritis Market Size (2019-2030)
7.2 Europe Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024)
7.4 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size (2019-2030)
8.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2019-2024)
8.4 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size (2019-2030)
9.2 Latin America Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024)
9.4 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size (2019-2030)
10.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024)
10.4 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medipost
11.1.1 Medipost Company Detail
11.1.2 Medipost Business Overview
11.1.3 Medipost Stem Cell Therapy for Osteoarthritis Introduction
11.1.4 Medipost Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.1.5 Medipost Recent Development
11.2 Nature Cell
11.2.1 Nature Cell Company Detail
11.2.2 Nature Cell Business Overview
11.2.3 Nature Cell Stem Cell Therapy for Osteoarthritis Introduction
11.2.4 Nature Cell Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.2.5 Nature Cell Recent Development
11.3 Theracell Advanced Biotechnology
11.3.1 Theracell Advanced Biotechnology Company Detail
11.3.2 Theracell Advanced Biotechnology Business Overview
11.3.3 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Introduction
11.3.4 Theracell Advanced Biotechnology Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.3.5 Theracell Advanced Biotechnology Recent Development
11.4 Takeda (TiGenix)
11.4.1 Takeda (TiGenix) Company Detail
11.4.2 Takeda (TiGenix) Business Overview
11.4.3 Takeda (TiGenix) Stem Cell Therapy for Osteoarthritis Introduction
11.4.4 Takeda (TiGenix) Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
11.4.5 Takeda (TiGenix) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Allogeneic
Table 3. Key Players of Autologous
Table 4. Global Stem Cell Therapy for Osteoarthritis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Stem Cell Therapy for Osteoarthritis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Stem Cell Therapy for Osteoarthritis Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Stem Cell Therapy for Osteoarthritis Market Share by Region (2019-2024)
Table 8. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Stem Cell Therapy for Osteoarthritis Market Share by Region (2025-2030)
Table 10. Stem Cell Therapy for Osteoarthritis Market Trends
Table 11. Stem Cell Therapy for Osteoarthritis Market Drivers
Table 12. Stem Cell Therapy for Osteoarthritis Market Challenges
Table 13. Stem Cell Therapy for Osteoarthritis Market Restraints
Table 14. Global Stem Cell Therapy for Osteoarthritis Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Stem Cell Therapy for Osteoarthritis Market Share by Players (2019-2024)
Table 16. Global Top Stem Cell Therapy for Osteoarthritis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy for Osteoarthritis as of 2023)
Table 17. Ranking of Global Top Stem Cell Therapy for Osteoarthritis Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Stem Cell Therapy for Osteoarthritis Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Stem Cell Therapy for Osteoarthritis Product Solution and Service
Table 21. Date of Enter into Stem Cell Therapy for Osteoarthritis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Stem Cell Therapy for Osteoarthritis Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2019-2024)
Table 25. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2025-2030)
Table 27. Global Stem Cell Therapy for Osteoarthritis Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2019-2024)
Table 29. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2025-2030)
Table 31. North America Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030) & (US$ Million)
Table 46. Medipost Company Detail
Table 47. Medipost Business Overview
Table 48. Medipost Stem Cell Therapy for Osteoarthritis Product
Table 49. Medipost Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024) & (US$ Million)
Table 50. Medipost Recent Development
Table 51. Nature Cell Company Detail
Table 52. Nature Cell Business Overview
Table 53. Nature Cell Stem Cell Therapy for Osteoarthritis Product
Table 54. Nature Cell Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024) & (US$ Million)
Table 55. Nature Cell Recent Development
Table 56. Theracell Advanced Biotechnology Company Detail
Table 57. Theracell Advanced Biotechnology Business Overview
Table 58. Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Product
Table 59. Theracell Advanced Biotechnology Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024) & (US$ Million)
Table 60. Theracell Advanced Biotechnology Recent Development
Table 61. Takeda (TiGenix) Company Detail
Table 62. Takeda (TiGenix) Business Overview
Table 63. Takeda (TiGenix) Stem Cell Therapy for Osteoarthritis Product
Table 64. Takeda (TiGenix) Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024) & (US$ Million)
Table 65. Takeda (TiGenix) Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stem Cell Therapy for Osteoarthritis Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Stem Cell Therapy for Osteoarthritis Market Share by Type: 2023 VS 2030
Figure 3. Allogeneic Features
Figure 4. Autologous Features
Figure 5. Global Stem Cell Therapy for Osteoarthritis Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Stem Cell Therapy for Osteoarthritis Market Share by Application: 2023 VS 2030
Figure 7. Primary Osteoarthritis Case Studies
Figure 8. Secondary Osteoarthritis Case Studies
Figure 9. Stem Cell Therapy for Osteoarthritis Report Years Considered
Figure 10. Global Stem Cell Therapy for Osteoarthritis Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Stem Cell Therapy for Osteoarthritis Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Stem Cell Therapy for Osteoarthritis Market Share by Region: 2023 VS 2030
Figure 13. Global Stem Cell Therapy for Osteoarthritis Market Share by Players in 2023
Figure 14. Global Top Stem Cell Therapy for Osteoarthritis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy for Osteoarthritis as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Stem Cell Therapy for Osteoarthritis Revenue in 2023
Figure 16. North America Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Stem Cell Therapy for Osteoarthritis Market Share by Country (2019-2030)
Figure 18. United States Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Stem Cell Therapy for Osteoarthritis Market Share by Country (2019-2030)
Figure 22. Germany Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Share by Region (2019-2030)
Figure 30. China Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Stem Cell Therapy for Osteoarthritis Market Share by Country (2019-2030)
Figure 38. Mexico Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Country (2019-2030)
Figure 42. Turkey Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Medipost Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
Figure 45. Nature Cell Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
Figure 46. Theracell Advanced Biotechnology Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
Figure 47. Takeda (TiGenix) Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Table 1. Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Allogeneic
Table 3. Key Players of Autologous
Table 4. Global Stem Cell Therapy for Osteoarthritis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Stem Cell Therapy for Osteoarthritis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Stem Cell Therapy for Osteoarthritis Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Stem Cell Therapy for Osteoarthritis Market Share by Region (2019-2024)
Table 8. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Stem Cell Therapy for Osteoarthritis Market Share by Region (2025-2030)
Table 10. Stem Cell Therapy for Osteoarthritis Market Trends
Table 11. Stem Cell Therapy for Osteoarthritis Market Drivers
Table 12. Stem Cell Therapy for Osteoarthritis Market Challenges
Table 13. Stem Cell Therapy for Osteoarthritis Market Restraints
Table 14. Global Stem Cell Therapy for Osteoarthritis Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Stem Cell Therapy for Osteoarthritis Market Share by Players (2019-2024)
Table 16. Global Top Stem Cell Therapy for Osteoarthritis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy for Osteoarthritis as of 2023)
Table 17. Ranking of Global Top Stem Cell Therapy for Osteoarthritis Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Stem Cell Therapy for Osteoarthritis Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Stem Cell Therapy for Osteoarthritis Product Solution and Service
Table 21. Date of Enter into Stem Cell Therapy for Osteoarthritis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Stem Cell Therapy for Osteoarthritis Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2019-2024)
Table 25. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2025-2030)
Table 27. Global Stem Cell Therapy for Osteoarthritis Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2019-2024)
Table 29. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2025-2030)
Table 31. North America Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2025-2030) & (US$ Million)
Table 46. Medipost Company Detail
Table 47. Medipost Business Overview
Table 48. Medipost Stem Cell Therapy for Osteoarthritis Product
Table 49. Medipost Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024) & (US$ Million)
Table 50. Medipost Recent Development
Table 51. Nature Cell Company Detail
Table 52. Nature Cell Business Overview
Table 53. Nature Cell Stem Cell Therapy for Osteoarthritis Product
Table 54. Nature Cell Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024) & (US$ Million)
Table 55. Nature Cell Recent Development
Table 56. Theracell Advanced Biotechnology Company Detail
Table 57. Theracell Advanced Biotechnology Business Overview
Table 58. Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Product
Table 59. Theracell Advanced Biotechnology Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024) & (US$ Million)
Table 60. Theracell Advanced Biotechnology Recent Development
Table 61. Takeda (TiGenix) Company Detail
Table 62. Takeda (TiGenix) Business Overview
Table 63. Takeda (TiGenix) Stem Cell Therapy for Osteoarthritis Product
Table 64. Takeda (TiGenix) Revenue in Stem Cell Therapy for Osteoarthritis Business (2019-2024) & (US$ Million)
Table 65. Takeda (TiGenix) Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stem Cell Therapy for Osteoarthritis Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Stem Cell Therapy for Osteoarthritis Market Share by Type: 2023 VS 2030
Figure 3. Allogeneic Features
Figure 4. Autologous Features
Figure 5. Global Stem Cell Therapy for Osteoarthritis Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Stem Cell Therapy for Osteoarthritis Market Share by Application: 2023 VS 2030
Figure 7. Primary Osteoarthritis Case Studies
Figure 8. Secondary Osteoarthritis Case Studies
Figure 9. Stem Cell Therapy for Osteoarthritis Report Years Considered
Figure 10. Global Stem Cell Therapy for Osteoarthritis Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Stem Cell Therapy for Osteoarthritis Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Stem Cell Therapy for Osteoarthritis Market Share by Region: 2023 VS 2030
Figure 13. Global Stem Cell Therapy for Osteoarthritis Market Share by Players in 2023
Figure 14. Global Top Stem Cell Therapy for Osteoarthritis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy for Osteoarthritis as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Stem Cell Therapy for Osteoarthritis Revenue in 2023
Figure 16. North America Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Stem Cell Therapy for Osteoarthritis Market Share by Country (2019-2030)
Figure 18. United States Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Stem Cell Therapy for Osteoarthritis Market Share by Country (2019-2030)
Figure 22. Germany Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Share by Region (2019-2030)
Figure 30. China Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Stem Cell Therapy for Osteoarthritis Market Share by Country (2019-2030)
Figure 38. Mexico Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Country (2019-2030)
Figure 42. Turkey Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Medipost Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
Figure 45. Nature Cell Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
Figure 46. Theracell Advanced Biotechnology Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
Figure 47. Takeda (TiGenix) Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2019-2024)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232